Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CC2202
- Development stage
- Preclinical
- Lead developer
- CirCode Bio
- Modality
- Long Non-coding RNA (lncRNA) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous
01
Overview
CC2202 is an investigational circular RNA (circRNA) therapeutic candidate developed by CirCode Bio (环码生物) for the treatment of oncology indications. Utilizing CirCode's proprietary circular RNA platform, CC2202 is designed to overcome the stability limitations of traditional linear mRNA. Circular RNAs are covalently closed loops that lack 5' and 3' ends, making them resistant to exonuclease-mediated degradation and potentially allowing for more sustained and robust protein expression within target cells. CC2202 is typically formulated with lipid nanoparticles (LNPs) for delivery and is intended to express therapeutic proteins that modulate the tumor microenvironment or directly inhibit tumor growth. It is currently in the preclinical stage of development.
- Other names
- CC2202-环码
Beyond the preview
Go deeper on CC2202.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CC2202.